These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 28780919)

  • 1. Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma.
    Bini I; Asaftei SD; Riggi C; Tirtei E; Manicone R; Biasin E; Basso ME; Agnoletti G; Fagioli F
    Cardiol Young; 2017 Nov; 27(9):1815-1822. PubMed ID: 28780919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
    Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D
    BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.
    Brown TR; Vijarnsorn C; Potts J; Milner R; Sandor GG; Fryer C
    Pediatr Blood Cancer; 2013 May; 60(5):842-8. PubMed ID: 23382019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cardiotoxicity of anthracycline-containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single-center real-world experience.
    Mo Z; Deng Y; Bao Y; Liu J; Jiang Y
    Cancer Med; 2023 Dec; 12(24):21709-21724. PubMed ID: 38054208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are cardiac magnetic resonance imaging and radionuclide ventriculography good options against echocardiography for evaluation of anthracycline induced chronic cardiotoxicity in childhood cancer survivors?
    Basar EZ; Corapcioglu F; Babaoglu K; Anik Y; Gorur Daglioz G; Dedeoglu R
    Pediatr Hematol Oncol; 2014 Apr; 31(3):237-52. PubMed ID: 24499452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity.
    Khan AA; Ashraf A; Singh R; Rahim A; Rostom W; Hussain M; Renner I; Collins NJ
    Intern Med J; 2017 Jan; 47(1):104-109. PubMed ID: 27800661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
    Conyers R; Costello B; La Gerche A; Tripaydonis A; Burns C; Ludlow L; Lange P; Ekert P; Mechinaud F; Cheung M; Martin M; Elliot D
    Intern Med J; 2017 Oct; 47(10):1166-1172. PubMed ID: 28485067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced cardiotoxicity in children.
    Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
    Creutzig U; Diekamp S; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2007 Jun; 48(7):651-62. PubMed ID: 17183582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and pattern of cardiotoxicity in pediatric Ewing sarcoma.
    Moussa E; Zamzam M; Kamel A; Salah Z; Attia I; Gaber L; Soliman R; Ezzat S
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):53-56. PubMed ID: 28258912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients.
    Kakadekar AP; Sandor GG; Fryer C; Chan KW; Rogers PC; Pritchard S; Popov R
    Med Pediatr Oncol; 1997 Jan; 28(1):22-6. PubMed ID: 8950332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors of Daunorubicine Induced Early Cardiotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Study.
    Samosir SM; Utamayasa IKA; Andarsini MR; Rahman MA; Ontoseno T; Hidayat T; Ugrasena IDG; Larasati MCS; Cahyadi A
    Asian Pac J Cancer Prev; 2021 May; 22(5):1407-1412. PubMed ID: 34048168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.
    Jones RL; Wagner AJ; Kawai A; Tamura K; Shahir A; Van Tine BA; Martín-Broto J; Peterson PM; Wright J; Tap WD
    Clin Cancer Res; 2021 Jul; 27(14):3861-3866. PubMed ID: 33632930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
    Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
    Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
    Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
    Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Echocardiography as Screening for Late-onset Anthracycline-induced Cardiotoxicity in Pediatric Cancer Survivors: Observations from the First Decade After End of Therapy.
    Moke DJ; Schubert LE; Sun HY; Printz BF; Dietz AC
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e283-e288. PubMed ID: 29432303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of anthracycline-induced cardiotoxicity in a retro-prolective cohort of children surviving cancer.
    Rivas-Ruiz R; Ureña-Wong K; Castelán-Martínez OD; Betanzos-Cabrera Y; Lazo-Cárdenas C; Ramírez-Portillo C; López-Aguilar E
    Gac Med Mex; 2020; 156(3):217-223. PubMed ID: 32539021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.